MN HF2834

Health care providers or clinic staff must notify patients (or parents/guardians for patients under 18) in writing whether aborted fetal tissue was or was not used in the research, development, or manufacture of any medication, medical equipment, or medical device before prescribing, administering, issuing, or recommending such items.

Notice must be provided separately from all other notices given to the patient, parent, or legal guardian.

Patients may sue manufacturers for damages if the manufacturer disclosed that aborted fetal tissue was not used when it actually was, the manufacturer knew or should have known the disclosure was inaccurate, and the patient relied on that information when consenting to use the medication, equipment, or device.

Patients may sue health care providers for damages if the provider prescribed or administered the item while providing notice that aborted fetal tissue was not used, knowing that information was inaccurate.

Defines "aborted fetal tissue" as fetal tissue available as a result of elective abortion, and excludes tissue from placenta, umbilical cord, or amniotic fluid.